EPO Patents = 1

Trademarks = 4

Forward Citations = 24

Loading Chart...

8 inventors (with patents filed for the assignee):

Peter Robert Baum (6 out of 31 patents)

Sean Wesley Smith (5 out of 5 patents)

Craig Alan Coburn (4 out of 58 patents)

4. Philip Tan (2 out of 8 patents)

5. Brenda L Stevens (2 out of 17 patents)

6. Robert Dubose (2 out of 3 patents)

7. Valerie Odegard (2 out of 4 patents)

8. Peter A Thompson (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11541126 - Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof (2023-01-03),

2. 11179473 - Nectin-4 antibody conjugates and uses thereof (2021-11-23),

3. 10519131 - Benzazepine compounds, conjugates, and uses thereof (2019-12-31),

4. 10442790 - Benzazepine compounds, conjugates, and uses thereof (2019-10-15),

5. 10428045 - Benzazepine compounds, conjugates, and uses thereof (2019-10-01),

6. 10239862 - Benzazepine compounds, conjugates, and uses thereof (2019-03-26),

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology therapies. Their lead product candidate is designed to activate an immune response to selectively target cancer cells. Their innovative approach holds promise for improving outcomes for cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#291 in Seattle, WA

#1,011 in Washington

#43,795 in US

Seattle, WA, United States of America

Silverback Therapeutics, Inc.